Rick Larsen, the Washington Democrat who's held the 2nd Congressional District since 2001, is drawing attention this week with essentially no news hook to explain it. Zero stories in the Google News feed. Six posts on Bluesky, mostly from a constituent announcing they're voting against him over AIPAC donations and arms votes. Not breaking news — just the ambient hum of a long-serving member who's been around long enough to generate opinions. Here's what the financial record looks like while that hum plays.
The One Trade
Larsen filed one disclosed stock trade in the last 90 days. On July 8, he sold shares of Abbott Laboratories (ABT), somewhere in the $1,001 to $15,000 range. Per the disclosure filing, that's the full picture. One sale, a medical device and diagnostics giant, nothing in the legislative pipeline with an obvious ABT angle on Larsen's plate.
Abbott is not in the jurisdiction of the House Committee on Transportation and Infrastructure, which is Larsen's committee. Abbott makes blood glucose monitors and cardiac devices. Larsen oversees roads, bridges, railroads, and aviation. No committee overlap. File the ABT sale as a trade, not a conflict.
What's more interesting is the broader pattern it sits inside.
The 21-Trade Record, Honestly
Blind Trust has scored 21 of Larsen's recent trades against the S&P 500 over 30-day windows. The record: 8 positive, 13 negative. Mean 30-day alpha: -1.7%.
Eight wins and thirteen losses means he's on the wrong side of the market more often than not, and the losses outrun the wins in aggregate. This is the full scored sample. The complete disclosure record is public.
The best single trade in the set: a purchase of Carrier Global (CARR) on April 7, 2026, which logged +11.3% alpha over the following 30 days. That one carries a committee overlap flag — Carrier makes HVAC systems and sits adjacent to the building and infrastructure space that Transportation and Infrastructure touches. Whether that explains the timing is a question the data can raise but not answer.
The worst single trade: a sale of American Water Works (AWK), also on April 7, which went -16.7% against the market in the same window. AWK also carries a committee overlap flag, under utilities. So on the same day, one committee-adjacent sale aged badly and one committee-adjacent purchase aged well. The net of those two alone is roughly flat. The broader portfolio is not.
The second-worst: a sale of Broadridge Financial Solutions (BR), April 7, -14.6% alpha. No committee overlap. Just a trade that went the wrong direction.
The Votes This Month
Larsen has been busy on the floor in July, and the pattern is consistent: voting no on bills that pass anyway.
On July 21, he voted Nay on the Main Street Capital Access Act, which passed. On July 14, he voted Nay on the Protecting Privacy in Purchases Act, which also passed. On July 22, he cast a string of Nay votes on amendments to the National Defense Authorization Act for Fiscal Year 2027, then voted Nay on final passage — which passed.
The NDAA votes carry no committee-level conflict angle. Larsen sits on Transportation and Infrastructure, not Armed Services. Floor votes on bills outside a member's committee jurisdiction are standard — no special oversight implied.
The Protecting Privacy in Purchases Act is worth noting. Bills touching consumer financial data carry obvious downstream effects for financial and tech sectors. Larsen voted against it; it passed without him. The ABT sale happened six days before that vote. The brief shows no overlap in the data and supports no causal claim. The calendar just sits there.
The Bluesky Subtext
The social chatter is about his votes on Israel and arms shipments, not his portfolio. One constituent post getting traction says flatly: he takes AIPAC money, voted to keep sending weapons, and they're backing his challenger, Thomas Scheel.
A second post flags an earlier trade. Per that post, Larsen purchased up to $15,000 of Amphenol (APH) on July 12, disclosing it four days later — and then Rep. Dan Newhouse, a Washington Republican, filed his own APH purchase shortly after, also capped at $15,000. Two Washington members, same stock, close timing. The data brief we're working from shows only the ABT sale, so we're not running past our headlights on the APH detail. The public record is what it is.
What the Disclosure System Requires
Members must file trades within 45 days. They are not required to divest from sectors they regulate, recuse from relevant votes, or explain their timing. The filing is the floor, not the ceiling.
Larsen's 8-for-21 record puts him among members who are not beating the market in their personal accounts. The committee-overlap trades cut in opposite directions — the CARR purchase at +11.3% is his best scored outcome; the AWK sale at -16.7% is one of his worst. Both carry the same committee-adjacent flag. Which one you lead with says more about your priors than about the data.
What the Record Shows
One trade in the last 90 days. Thirteen losses out of 21 scored positions. A mean alpha of -1.7%. A July voting record of Nay votes on bills that passed without him. Bluesky attention driven by foreign policy grievances, not financial disclosures.
The full record is public. His financial disclosures show a member who is not outperforming the market and is not generating obvious vote-trade overlaps in recent data. Whether any of that is relevant to why his constituents are annoyed with him this week is a question the disclosures don't answer.
The receipts are public. Make of them what you make of them.